APA (7th ed.) Citation

E, U., J, S., C, P., W, P., Q, Z., N, D., . . . N, E. (2026). Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies. Blood cancer journal, 16(1), . https://doi.org/10.1038/s41408-026-01471-5

Chicago Style (17th ed.) Citation

E, Umyarova, Sharp J, Pei C, Pellegrino W, Zhao Q, Denlinger N, Voorhees T, De Lima M, and Epperla N. "Cutaneous Adverse Events Following CAR T-cell Therapy in Hematologic Malignancies." Blood Cancer Journal 16, no. 1 (2026). https://doi.org/10.1038/s41408-026-01471-5.

MLA (9th ed.) Citation

E, Umyarova, et al. "Cutaneous Adverse Events Following CAR T-cell Therapy in Hematologic Malignancies." Blood Cancer Journal, vol. 16, no. 1, 2026, https://doi.org/10.1038/s41408-026-01471-5.